Trevi shareholders approve 6M share increase for 2019 Stock Incentive Plan

Trevi Therapeutics, Inc.

Stockholders voted to increase authorized shares under the 2019 Plan by 6,000,000 shares.
Class III directors Jennifer Good and Anne VanLent re-elected with 78.8M and 62.9M votes for, respectively.
Ratification of Ernst & Young as auditor for FY2025 passed with 88.9M votes for.
Advisory say-on-pay approved (78.3M for, 0.7M against); future votes will be held every year.
All proposals, including the equity plan amendment, received required majority approval.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.